Barclays upgrades Aviva to 'overweight,' citing growth from Direct Line deal

Published 14/02/2025, 13:36
© Reuters

Investing.com -- Barclays (LON:BARC) has upgraded Aviva (LON:AV) to an 'overweight' from ‘equal weight’ rating, citing the insurer’s proposed acquisition of Direct Line (LON:DLGD) Group (DLG) as a key driver of future growth. 

In a note dated Friday, analysts at Barclays flagged the benefits of the deal, which is expected to generate long-term synergies and earnings growth.

The analysts believe Aviva's management has been conservative in its projections for the acquisition's financial impact. 

While Aviva has estimated an earnings per share (EPS) accretion of around 10% by 2029, Barclays forecasts a higher increase of approximately 13%. 

The brokerage also raised its price target for Aviva’s stock by 5%, moving it from 540 pence to 565 pence, indicating a potential upside of 12%.

Barclays' assessment underscores the operational efficiencies that Aviva is expected to achieve by integrating Direct Line’s business into its own. 

Analysts estimate that Aviva can realize cost synergies amounting to 30% of Direct Line’s addressable cost base, equivalent to roughly £196 million, compared to Aviva’s more cautious projection of £125 million. 

While the restructuring and integration costs could be higher than Aviva’s estimates, Barclays anticipates the deal will be accretive to earnings from the first year onward.

The brplerahe also addressed concerns regarding Aviva’s capital position, noting that while the transaction will temporarily raise the insurer’s Solvency II leverage ratio to around 30.4%, this is not expected to pose a long-term issue for equity investors. 

Barclays projects that Aviva’s Solvency II ratio will initially decline but recover beyond management’s target range of 160-180% from 2025 onwards, allowing the company to reinstate share buybacks of £300 million annually from 2026.

The note reflects a broader confidence in Aviva’s direction, particularly its efforts to consolidate its position in the UK insurance market. 

The proposed acquisition, still awaiting regulatory approval and shareholder votes in March, is seen as a move that will enhance Aviva’s scale and competitive edge in the sector.

Aviva’s stock was last trading at 503 pence, with Barclays' revised target price suggesting an all-in return of approximately 19%, including dividends. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.